2000Anesthesia & AnalgesiaRequires access

Hetastarch and Hydroxyethyl Starch Are Not the Same

Gregory A. Nuttall

Open publisher page 2 citations

Abstract

In Response: I would like to thank Dr. Huettemann for his thoughtful letter to the editor. As noted by Treib et al. (1), there is only one type of hydroxyethyl starch available in the United States, whereas several hydroxyethyl starch preparations are widely used in Europe. The results of our study should only be applied to the preparation used in the United States (Hespan®, Abbott Laboratories, North Chicago, IL; average molecular weight 450,000 daltons, substitution of 0.7) or similar European preparations, because they induce a greater degree of anticoagulation than the smaller, more easily degraded hydroxyethyl starch preparations (1). Furthermore, as the anticoagulant effects of hydroxyethyl starch may potentiate the known coagulopathic state induced by cardiopulmonary bypass and exacerbate bleeding, the results of our study can only be applied to patients undergoing cardiopulmonary bypass. Gregory A. Nuttall MD

About this research paper

What this paper is about

In Response: I would like to thank Dr. Huettemann for his thoughtful letter to the editor. As noted by Treib et al. (1), there is only one type of hydroxyethyl starch available in the United States, whereas several hydroxyethyl starch preparations are widely used in Europe. The results of our study should only be applied to the preparation used in the United States (Hespan®, Abbott Laboratories, North Chicago, IL; average molecular weight 450,000 daltons, substitution of 0.7) or similar European preparations, because they induce a greater degree of anticoagulation than the smaller, more easily degraded hydroxyethyl starch preparations (1). Furthermore, as the anticoagulant effects of hydroxyethyl starch may potentiate the known coagulopathic state induced by cardiopulmonary bypass and exacerbate bleeding, the results of our study can only be applied to patients undergoing cardiopulmonary bypass. Gregory A. Nuttall MD

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In Response: I would like to thank Dr. Huettemann for his thoughtful letter to the editor. As noted by Treib et al. (1), there is only one type of hydroxyethyl starch available in the United States, whereas several hydroxyethyl starch preparations are widely used in Europe. The results of our study should only be applied to the preparation used in the United States (Hespan®, Abbott Laboratories, North Chicago, IL; average molecular weight 450,000 daltons, substitution of 0.7) or similar European preparations, because they induce a greater degree of anticoagulation than the smaller, more easily degraded hydroxyethyl starch preparations (1). Furthermore, as the anticoagulant effects of hydroxyethyl starch may potentiate the known coagulopathic state induced by cardiopulmonary bypass and exacerbate bleeding, the results of our study can only be applied to patients undergoing cardiopulmonary bypass. Gregory A. Nuttall MD

Key concepts: Hydroxyethyl starch, Hetastarch, Medicine, Cardiopulmonary bypass, Starch, Anesthesia, Biochemistry, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Hetastarch and Hydroxyethyl Starch Are Not the Same — Research Paper | ScholarLens